These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Haemophagocytic lymphohistiocytosis: a cause of unresponsive malaria in a 5-year-old girl. Bhagat M, Kanhere S, Kadakia P, Phadke V, George R, Chaudhari K. Paediatr Int Child Health; 2015 Dec; 35(4):333-6. PubMed ID: 26744159 [Abstract] [Full Text] [Related]
5. Profound thrombocytopenia in Plasmodium vivax malaria. Kakar A, Bhoi S, Prakash V, Kakar S. Diagn Microbiol Infect Dis; 1999 Nov; 35(3):243-4. PubMed ID: 10626136 [Abstract] [Full Text] [Related]
9. Alteration of platelet counts and lipid profiles after treatment of acute Plasmodium vivax. Kim JS, Oh JS, Chang EA, Bae SY, Nam DH, Lee CH, Yang JH, Lee CK, Lee WJ, Kim HC, Klein TA, Lim CS, Kim YK. Acta Trop; 2008 Apr; 106(1):39-43. PubMed ID: 18304498 [Abstract] [Full Text] [Related]
10. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials. Phommasone K, van Leth F, Peto TJ, Landier J, Nguyen TN, Tripura R, Pongvongsa T, Lwin KM, Kajeechiwa L, Thwin MM, Parker DM, Wiladphaingern J, Nosten S, Proux S, Nguon C, Davoeung C, Rekol H, Adhikari B, Promnarate C, Chotivanich K, Hanboonkunupakarn B, Jittmala P, Cheah PY, Dhorda M, Imwong M, Mukaka M, Peerawaranun P, Pukrittayakamee S, Newton PN, Thwaites GE, Day NPJ, Mayxay M, Hien TT, Nosten FH, Cobelens F, Dondorp AM, White NJ, von Seidlein L. PLoS One; 2020 Apr; 15(2):e0228190. PubMed ID: 32023293 [Abstract] [Full Text] [Related]
11. Spontaneous chronic subdural hematoma following Plasmodium vivax malaria: a rare association. Thirumal Y, Alugolu R. J Vector Borne Dis; 2014 Mar; 51(1):73-4. PubMed ID: 24717209 [No Abstract] [Full Text] [Related]
13. Five cases of Plasmodium vivax malaria treated with artemisinin derivatives: the advantages of a unified approach to treatment. Corpolongo A, Pisapia R, Oliva A, Giancola ML, Mencarini P, Bevilacqua N, Ghirga P, Mariano A, Vulcano A, Paglia MG, Nicastri E. Infection; 2019 Aug; 47(4):655-659. PubMed ID: 30809760 [Abstract] [Full Text] [Related]
15. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report. He X, Pan M, Zeng W, Zou C, Pi L, Qin Y, Zhao L, Qin P, Lu Y, Baird JK, Huang Y, Cui L, Yang Z. BMC Infect Dis; 2019 Aug 09; 19(1):704. PubMed ID: 31399061 [Abstract] [Full Text] [Related]
16. Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial. Daher A, Pereira D, Lacerda MVG, Alexandre MAA, Nascimento CT, Alves de Lima E Silva JC, Tada M, Ruffato R, Maia I, Dos Santos TC, Marchesini P, Santelli AC, Lalloo DG. Malar J; 2018 Jan 24; 17(1):45. PubMed ID: 29361939 [Abstract] [Full Text] [Related]
17. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand. Hamedi Y, Safa O, Zare S, Tan-ariya P, Kojima S, Looareesuwan S. Southeast Asian J Trop Med Public Health; 2004 Sep 24; 35(3):570-4. PubMed ID: 15689068 [Abstract] [Full Text] [Related]
19. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. Yadav RS, Ghosh SK. J Parasitol; 2002 Oct 24; 88(5):1042-4. PubMed ID: 12435158 [Abstract] [Full Text] [Related]